摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-Chloro-3-cyclohexyl-2,4-dihydropyrido[3,2-h][1,3]benzoxazine

中文名称
——
中文别名
——
英文名称
6-Chloro-3-cyclohexyl-2,4-dihydropyrido[3,2-h][1,3]benzoxazine
英文别名
——
6-Chloro-3-cyclohexyl-2,4-dihydropyrido[3,2-h][1,3]benzoxazine化学式
CAS
——
化学式
C17H19ClN2O
mdl
——
分子量
302.8
InChiKey
FENILMJBVROUET-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.3
  • 重原子数:
    21
  • 可旋转键数:
    1
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.47
  • 拓扑面积:
    25.4
  • 氢给体数:
    0
  • 氢受体数:
    3

文献信息

  • Methionine Aminopeptidase Inhibitors for Treating Infectious Diseases
    申请人:Olaleye Omonike Arike
    公开号:US20150141415A1
    公开(公告)日:2015-05-21
    The present invention relates to methods for treating an infectious disease in a subject in need thereof via administration of a therapeutically effective amount of compounds described herein. The methods may utilize particular compounds, for example, a quinoline, a hydrazone, a quinone, or a pyrimidine derivatives thereof or a pharmaceutical salts thereof.
  • Formulations of Methionine Aminopeptidase Inhibitors for Treating Infectious Diseases
    申请人:Olaleye Omonike A.
    公开号:US20170304288A1
    公开(公告)日:2017-10-26
    Provided herein are formulations and co-solvent formulations and methods for treating an infectious disease utilizing the same. The formulations and co-solvent formulations may comprise a hydroxyquinoline analog or its pharmaceutically acceptable salt, a solvent and at least two surfactants. Also provided are methods of quantitating a hydroxyquinoline analog in a sample via chromatographic/spectrometric measurements.
  • [EN] METHIONINE AMINOPEPTIDASE INHIBITORS FOR TREATING INFECTIOUS DISEASES<br/>[FR] INHIBITEURS DE LA MÉTHIONINE AMINOPEPTIDASE POUR LE TRAITEMENT DE MALADIES INFECTIEUSES
    申请人:TEXAS SOUTHERN UNIVERSITY
    公开号:WO2015077057A1
    公开(公告)日:2015-05-28
    The present invention relates to methods for treating an infectious disease in a subject in need thereof via administration of a therapeutically effective amount of compounds described herein. The methods may utilize particular compounds, for example, a quinoline, a hydrazone, a quinone, or a pyrimidine derivatives thereof or a pharmaceutical salts thereof.
查看更多